Invest on your own
Build your own portfolio, stock by stock.
We do it for you
Professionally managed portfolios, built and rebalanced for you.
NEW
How we screen every stock
Our halal screening & purification process in 3 minutes
Screeners
Your portfolio
Calculators
TOOL
Check any stock in seconds
Search 11,000+ tickers and see the halal verdict instantly.
Our certifications
Independent proof that every stock and portfolio meets halal standards.
METHODOLOGY
How we screen every stock
Our 5-step halal methodology, in 90 seconds.
Get help
NEW
Halal investing 101
A beginner-friendly intro to investing the halal way.
Plans by product
COMPARE
Find your plan
See every feature side-by-side and pick what fits.
Investors
INVESTORS
Invest in Musaffa
We're building the financial house for 1.9B Muslims. See the deck.
Proto Script Pharmaceutical Corp. Stock Analysis PSCR
United States N/A Nano Cap Proto Script Pharmaceutical Corp. engages in the provision of mobility solutions. The company is headquartered in Rancho Cucamonga, California. The company went IPO on 2011-11-25. The firm is primarily in the business of repair power wheelchairs and scooters, which are classified as durable medical equipment (DME) products and reimbursable by healthcare insurance providers. The firm has various contracts with state and governmental insurance providers, among others. These contracts provide the Company the right to sell and repair DME. The firm's health care insurance contracts allow it the ability to service patients nationally. The firm intends to expand its market through additional contracts and open several repair facilities throughout the continental United States. The firm currently has repair facilities in Las Vegas, Nevada, Rancho-Cucamonga, and Anaheim, California. As of June 30, 2016, the Company had not generated any revenues.
Read More Proto Script Pharmaceutical Corp (PSCR) Chart
Key Statistics of Proto Script Pharmaceutical Corp (PSCR)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$0.00Volume
100.00P/E Ratio (TTM)
-52 Week Range
Market Cap
5690.40Avg. Volume
4866.67Dividend Yield
-Financial Metrics & Statements of Proto Script Pharmaceutical Corp (PSCR)
FAQ's for Proto Script Pharmaceutical Corp (PSCR)
- According to Musaffa’s Shariah screening methodology, Proto Script Pharmaceutical Corp (PSCR) is currently classified as NOT COVERED as of June 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.
- A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Proto Script Pharmaceutical Corp using these criteria to determine its compliance status.
- Muslim investors may consider investing in Proto Script Pharmaceutical Corp if it meets Shariah compliance standards. Investors typically review the company’s business activities, debt levels, and non-permissible income before making a decision.
- Musaffa determines the Shariah status of Proto Script Pharmaceutical Corp by analyzing whether the company’s core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.
- The Shariah compliance status of Proto Script Pharmaceutical Corp may be updated periodically when new financial statements, earnings reports, or business activity information become available.
- Yes. A stock that is currently Shariah-compliant may become non-compliant if the company’s financial ratios exceed Shariah thresholds or its business activities change.
- You can check the latest Shariah compliance status of Proto Script Pharmaceutical Corp on Musaffa’s stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.